Pamela Phumelele Mkhize

Dr. Pamela Phumelele Mkhize

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2024 in Viruses
Verified
Journal Article
Open access
PDF file
CMCarol Maswanganye
Carol Maswanganye
PMPamela Phumelele Mkhize
Pamela Phumelele Mkhize
NMNontokozo D. Matume
Nontokozo D. Matume
This systematic review and meta-analysis evaluate human papillomavirus (HPV) prevalence, genotype distribution, and associations with cervicovaginal microbiota and cytokine profiles among South African women, where cervical cancer ranks as the second most common cancer. PubMed, SCOPUS, and Web of Science were searched for studies on HPV infection up to 21 September 2024. The pooled prevalence was estimated using a random-effects model, with subgroup analyses by province, sample type, and HIV status. Publication bias was evaluated using funnel plots and Egger’s test. Of the 19,765 studies screened, 120 met the inclusion criteria, comprising 83,266 participants. Results indicate a high HPV burden, with a pooled prevalence of 58% (95% CI: 52–64%), varying regionally from 53% (95% CI: 41–65%) to 64% (95% CI: 55–73%), with some regions under-researched. Cervical samples had the highest HPV prevalence (60% (95% CI: 54–66%)), while non-genital samples were less studied. High-risk (HR) HPV types, notably HPV 16 (7.5%), HPV 35 (4.1%), and HPV 18 (3.9%), were prominent, with HPV 35 emphasizing the need for expanded vaccine coverage. HIV-positive women had a higher pooled HPV prevalence (63% (95% CI: 55–71%)). Funnel plot analysis and Egger’s test suggested a potential publication bias (p = 0.047). HPV-positive women exhibited lower Lactobacillus levels and an increase in Bacterial Vaginosis (BV)-associated species like Gardnerella, potentially supporting HPV persistence. Cytokine analysis showed elevated MIP-1α and MIP-1β in HPV infections, though cytokine profiles may depend on HPV genotypes. These findings underscore the need for research on HPV–microbiome-immune interactions and call for comprehensive HPV-prevention strategies, including vaccines targeting regional HPV types and tailored interventions for HIV-positive populations.

29 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZGZanenhlanhla Gumbi
Zanenhlanhla Gumbi
CMCelia Mehou-Loko
Celia Mehou-Loko
LMLindi Masson
Lindi Masson
MMMakhosazana Mdladla
Makhosazana Mdladla
NMNokuthula Maphumulo
Nokuthula Maphumulo
HHHilton Humphries
Hilton Humphries
Purpose: Adolescent girls are at high risk for depression and human immunodeficiency virus (HIV) acquisition. Poor mental health can increase vulnerability to risky sexual behaviours. Therefore, this study aims to determine the prevalence of depressive symptomology and explore the convergence of HIV risk factors with depressive symptoms amongst cis-gender adolescent girls and young women (AGYW) in rural KwaZulu-Natal (KZN) and peri-urban Western Cape (WC) communities in South Africa. Methods: Cross-sectional survey data from two sites in South Africa was used - the rural Vulindlela community in KZN and the peri-urban Philippi East community in the WC. Study inclusion criteria included being sexually active with at least one male partner, and not planning to relocate in the next 12 months. The PHQ-9 scale was used to determine depressive symptomology, a socio-behavioural questionnaire was used to determine sexual behaviours, odds ratios and confidence intervals derived from logistic regression models were used to explore the associations between depressive symptomology and socio-behavioural factors associated with HIV acquisition. Results: The cohort consisted of 274 adolescent girls, 38.6% from the WC site and 61.4% from the KZN site. Overall, 15.7% (43/274) of AGYW reported depressive symptoms. Participants from the peri-urban WC site were more likely to experience depressive symptoms (OR 8.34; 95% CI 3.80–18.30) compared to those living in the rural KZN site. Depressive symptoms were less likely to occur in adolescent girls between the ages of 14 to 17 as compared to those between the ages of 18 and 19 (OR 0.44; 95% CI 0.22–0.90). Socio-behavioural HIV risk factors associated with depressive symptoms include: age disparate relationships (OR 2.98; 95% CI 1.52–5.84), high (four or more) numbers of lifetime partners (OR 8.15; 95% CI 3.60–18.45) and engaging in sex under the influence of alcohol (OR 2.58; 95% CI 1.32–5.04). Multivariate analysis showed that participants from the WC site (AOR 5.25; 95% CI 1.95–14.17) had higher odds of experiencing depressive symptoms while participants with four or more lifetime partners (AOR 3.46; 95% CI 1.24–9.60) were at higher odds of experiencing depressive symptoms. Conclusion: In this cross-sectional study, depressive symptomology is associated with certain HIV risk behaviours. Longitudinal studies are required to test the causal relationship between depression and HIV acquisition and to better understand the geospatial differences observed.

Verified
Journal Article
Open access
PDF file
BNBabalwa Nyide
Babalwa Nyide
MTMiranda Thomas
Miranda Thomas
LBLawrence Banks
Lawrence Banks
PMPamela Phumelele Mkhize
Pamela Phumelele Mkhize
NMNontokozo D. Matume
Nontokozo D. Matume
High-risk human papillomavirus (HR-HPV) types exhibit an uneven global distribution, with types 35, 51, 56, and 59 being more prevalent in Africa yet not covered by current L1-based vaccines. The genetic diversity of HR-HPV oncoproteins in Africa remains poorly characterized, despite their potential as alternative vaccine targets. This study investigates the genetic diversity of HR-HPV types 16, 18, 35, 51, 56, and 59 to inform vaccine development. We analyzed 14,332 sequences from the NCBI Virus database and 222 HPV reference sequences from the Papillomavirus Episteme (PaVE) database using phylogenetic analysis and variant identification. HPV16 and HPV35 exhibited close evolutionary relatedness, which may indicate shared traits relevant to vaccine design, although functional implications remain to be experimentally validated. A key finding of the study was the discovery of novel non-synonymous mutations, including E148K in HPV35 E6, S63C in HPV16 E7 and S495F in HPV18 L1, as well as known oncogenic variants such as L83V (E6) and N29S (E7) in HPV16. These findings highlight significant intra- and inter-type diversity among African HR-HPVs. This study provides new insights into the genetic diversity and evolutionary relationships of underrepresented HR-HPV types. The findings underscore the need for continued genomic surveillance and support efforts to develop region-specific vaccines that include HPV35, 51, 56, and 59 to address gaps in current vaccine coverage and help reduce the burden of HPV-related cancers in Africa.

19 July 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SRSamukelisiwe Radebe
Samukelisiwe Radebe
PRPhumla Radebe
Phumla Radebe
ZGZanenhlanhla Gumbi
Zanenhlanhla Gumbi
RTRamla F. Tanko
Ramla F. Tanko
MMMonalisa Manhanzva
Monalisa Manhanzva
PMPamela Phumelele Mkhize
Pamela Phumelele Mkhize
Adolescent girls and young women (AGYW) in South Africa experience a disproportionate burden of HIV infection. Genital inflammation has been implicated in increased HIV susceptibility through enhanced availability of target immune cells; however, the effects of recent sexual activity and vaginal-stimulating product (VSP) use on mucosal immune responses remain incompletely defined. This study characterised mucosal immune profiles following recent sexual exposure and VSP use in adolescent and adult women. HIV-negative sexually active adolescents (14–19 years) and adult women (25–35 years) were enrolled in a longitudinal cohort in KwaZulu-Natal, South Africa. Cervical cytobrush samples and cervicovaginal secretions were collected at baseline (≥ 2 weeks abstinence) and following reported sexual activity and/or VSP use. Cervical T-cell activation markers (CD38, HLA-DR, CCR5, α4β7) were quantified by flow cytometry, and 18 cytokines and chemokines were measured using a multiplex assay. Associations with time since last sexual intercourse were assessed using correlation analyses, and factors associated with genital inflammation were evaluated using weighted logistic regression. Recent sexual activity showed inverse associations with several pro-inflammatory cytokines, including MIP-1α, IL-1α, IL-1β, GM-CSF, and IL-17, consistent with a transient pattern of mucosal immune activation following exposure. In multivariable models, recent sexual activity (OR 0.58; p = 0.009) and bacterial vaginosis (OR 2.38; p = 0.017) were independently associated with genital inflammation, whereas VSP use was not statistically significant after adjustment (OR 1.63; p = 0.187). Although higher cytokine concentrations were observed among VSP users in unadjusted analyses, including IL-1α in adolescents (p = 0.001) and MIP-1α in adults (p = 0.017), these associations did not remain significant after correction for multiple testing. Overall, these findings suggest that recent sexual activity is associated with transient changes in mucosal immune mediators, while VSP use does not independently predict genital inflammation in this cohort after adjustment for confounding and multiple testing. These results highlight the importance of timing of exposure in interpreting mucosal immune measurements and support further longitudinal studies with precise sampling intervals to better define post-coital immune dynamics and the role of behavioural practices in shaping genital immunity.

8 June 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
ZGZanenhlanhla Gumbi
Zanenhlanhla Gumbi
PRPhumla Radebe
Phumla Radebe
SSSengeziwe Sibeko
Sengeziwe Sibeko
BSBester Saruchera
Bester Saruchera
NMNokuthula Maphumulo
Nokuthula Maphumulo
PMPamela Phumelele Mkhize
Pamela Phumelele Mkhize
Colposcopy is used to evaluate cervical inflammation and detect precancerous and other cervical lesions; however, access remains limited in many low-resource settings. Identification of cervicovaginal immune biomarkers associated with specific colposcopic findings may provide insight into mucosal immune alterations linked to increased susceptibility to sexually transmitted infections (STIs) and human immunodeficiency virus (HIV), although these associations do not imply diagnostic or predictive utility in a cross-sectional context. In this exploratory cross-sectional study, 203 adolescent girls (14-19 years) and adult women (25-35 years) from KwaZulu-Natal (KZN; n = 105) and the Western Cape (WC; n = 98) underwent colposcopic assessment for cervical ectopy, discharge, injury/inflammation, and leukoplakia. Cervicovaginal cytokines were quantified using multiplex Luminex assays. Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and bacterial vaginosis (BV) were assessed. Logistic regression models identified correlates of colposcopic findings. Exploratory model performance metrics, including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), were calculated to describe within-dataset model behaviour. Overall, 75% of participants had at least one colposcopic finding. Leukoplakia was more prevalent in KZN (36% of adolescents and 22% of adults), while cervical discharge was most common in WC (36% in both age groups). In univariate analyses, injectable progestin use was associated with any colposcopic finding (OR = 2.10, p = 0.04), implant use was associated with ectopy in KZN (OR = 6.94, p = 0.04), and BV was associated with cervical discharge (OR = 3.37, p = 0.04). In the exploratory multivariable models, selected cervicovaginal cytokines showed finding- and site-specific associations with colposcopic outcomes. In KZN, higher granulocyte colony-stimulating factor (G-CSF) concentrations and parity were associated with cervical ectopy, while BV was associated with cervical discharge. In WC, interleukin-6 (IL-6) and macrophage inflammatory protein (MIP)-1β were associated with cervical ectopy, whereas lower MIP-1α concentrations were associated with leukoplakia. Measures of model performance varied across outcomes and sites, and should be interpreted within the context of the exploratory study design. Cervicovaginal cytokine profiles were differentially associated with specific colposcopic findings in a site-specific manner. These findings are exploratory and hypothesis-generating, highlighting potential biological correlates of cervical changes. Further validation in larger longitudinal cohorts is required to determine whether these cross-sectional associations are reproducible and biologically meaningful.